Lyell Immunopharma Inc
NASDAQ:LYEL
Lyell Immunopharma Inc
NASDAQ:LYEL
Price:
13.72
USD
5.78%
Market Closed
Market Cap:
$320.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
Biotest AG
XETRA:BIO
|
DE |
|
A
|
Aviat Networks Inc
SWB:HSD1
|
US |
Shareholder Yield
Current shareholder yield for LYEL is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
LYEL Price
Lyell Immunopharma Inc
Lyell Immunopharma Inc
Annual Price Range
13.72
52w Low
10.57
52w High
38.6
Price Metrics
| Average Annual Return | -53.37% |
| Standard Deviation of Annual Returns | 13.38% |
| Max Drawdown | -98% |
Shares Statistics
| Market Capitalization | 320.1m USD |
| Shares Outstanding | 23 330 000 |
| Percentage of Shares Shorted | 6.17% |
LYEL Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
LYEL's latest stock split occurred on Jun 2, 2025
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, LYEL traded at 0.437 per share. Afterward, the share price was about 8.22.
The adjusted shares began trading on Jun 2, 2025. This was the only stock split in LYEL's history.
Pre-Split Price
8.74
0.437
Post-Split Price
8.22
Before
After
